These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 7496647

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Double-blindness procedure did not mask giving of medication in panic disorder.
    Bakker A, Spinhoven P, van Balkom AJ, Matser D, van Dyck R.
    J Affect Disord; 1999 Jul; 54(1-2):189-92. PubMed ID: 10403163
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of panic disorder: focus on paroxetine.
    Pollack MH, Doyle AC.
    Psychopharmacol Bull; 2003 Jul; 37 Suppl 1():53-63. PubMed ID: 14566201
    [Abstract] [Full Text] [Related]

  • 26. Paroxetine-induced excessive yawning.
    Harada K.
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):260. PubMed ID: 16594955
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.
    Cohen LS, Soares CN, Yonkers KA, Bellew KM, Bridges IM, Steiner M.
    Psychosom Med; 2004 Apr; 66(5):707-13. PubMed ID: 15385695
    [Abstract] [Full Text] [Related]

  • 29. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G, Bertani A, Caldirola D, Smeraldi E, Bellodi L.
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.
    Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dubé EM.
    J Clin Psychiatry; 2002 Jul; 63(7):577-84. PubMed ID: 12143913
    [Abstract] [Full Text] [Related]

  • 31. A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.
    Liebowitz MR, Stein MB, Tancer M, Carpenter D, Oakes R, Pitts CD.
    J Clin Psychiatry; 2002 Jan; 63(1):66-74. PubMed ID: 11838629
    [Abstract] [Full Text] [Related]

  • 32. Changes in anxiety sensitivity with pharmacotherapy for panic disorder.
    Simon NM, Otto MW, Smits JA, Nicolaou DC, Reese HE, Pollack MH.
    J Psychiatr Res; 2004 Jan; 38(5):491-5. PubMed ID: 15380399
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
    Liebowitz MR, Gelenberg AJ, Munjack D.
    Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM, Gergel I, Li D.
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740.
    Bergink V, Westenberg HG.
    Int Clin Psychopharmacol; 2005 Nov; 20(6):291-3. PubMed ID: 16192835
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.